EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients with Hepatocellular Carcinoma

Naofumi Nagasue, Hirofumi Yukaya, Hitoshi Kohno, Yu-Chung Chang, Teruhisa Nakamura

HPB Surgery · 1988

DOI: 10.1155/1988/93437 ↗
AbstractBibliografische Angaben

Abstract

Major hepatic resection was carried out on 23 adult patients with hepatocellular carcinoma (HCC) and underlying cirrhosis of the liver (macronodular in six cases, micronodular in 11, and mixed type cirrhosis in six). Pre‐operative liver functional state was Child′s class A in 19, class B in three, and class C in one. The operations performed were extended right lobectomy in four patients, right lobectomy in 10, left lobectomy in one, and left lateral segmentectomy in eight. Fifteen postoperative complications were found in 10 patients, five of whom had duplicated complications and finally died of liver failure 15–65 days after operation. In three of those five patients, other complications (hemorrhagic shock in two and portal thrombosis in one) had preceded liver failure. Eighteen patients tolerated the resection and were discharged from hospital. However, among 13 noncirrhotic patients with HCC who had undergone major hepatic resection during the same period of time, only two had postoperative complications and all patients were discharged from hospital. The 1‐, 2‐ and 3‐year survival rates in the 23 cirrhotics were 60.9%, 37.5% and 24.9% respectively, whereas the 1–5‐year survival rates were all 61.5% in the 13 noncirrhotics. Thus, major hepatic resection may be indicated in selected patients with HCC and associated cirrhosis, but meticulous managements during and after operation are mandatory to prevent fatal postoperative liver failure.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →